Novo Nordisk A/S DPO Ratio 2011-2026 | NVO

Annual DPO Ratio Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	140	116	128	111	124	106	105	95.4

All numbers in DKK currency

Maximum	Minimum	Average
140	95.4	116

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
ACADIA Pharmaceuticals ACAD	75.2	$ 22.48	0.58 %	$ 3.73 B	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	7.93 K	$ 3.13	0.55 %	$ 651 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Exelixis EXEL	148	$ 48.55	9.3 %	$ 13.2 B	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.03	2.6 %	$ 3.06 B	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.73	5.18 %	$ 460 M	Britain
Fortress Biotech FBIO	400	$ 2.57	4.27 %	$ 71.7 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	30.3	-	-	-	Russia
Фармсинтез LIFE	306	-	-	-	Russia
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain